A B S T R A C T Some studies of animal models of serum-sickness nephritis have shown that the lesions of membranous nephropathy develop in animals exhibiting a poor antibody response to the administered antigen (if given in constant amounts). It is postulated that patients with idiopathic membranous nephropathy may share a similar characteristic, namely, a diminished capacity to produce sufficient amounts of antibody. To test this hypothesis, we examined the ability of lymphocytes isolated from 11 patients with this disorder to produce immunoglobulin (Ig)G and IgM on stimulation with a polyclonal B-cell activator, pokeweed mitogen. The peripheral blood lymphocytes (2 x 106 cells) from 24 normal individuals had geometric mean production rates of 1,779 ng for IgG, and 2,940 ng for IgM after 7 d of culture in the presence of pokeweed mitogen. By contrast, under identical conditions, lymphocytes from the 11 patients with membranous nephropathy produced significantly lower quantities of both immunoglobulins, with geometric mean concentrations of 511 ng for IgG and 439 ng for IgM. When lymphocytes from patients with membranous nephropathy were co-cultured with normal lymphocytes, the production of immunoglobulin by normal lvmphocytes was depressed by 22-82%, suggesting that a population ofsuppressor cells was responsible for this disturbance in B-cell function. By co-culturing normal lymphocytes with patient lymphocytes depleted of either T cells or monocytes, the suppressor cell was identified as a monocyte.
INTRODUCTION
Idiopathic membranous glomerulonephropathy is a form ofnephritis distinguished by the following characteristics: clinically, by an indolent course with gradual deterioration of renal function (1) ; pathologically, by the presence of subepithelial electron-dense deposits that, from animal studies, represent putative immune complexes formed in large antigen excess or reciprocally antibody deficiency (2) ; and immunopathologically, by the presence of granular deposits of immunoglobulin and complement in the glomerulus (3) , giving further corroboration to the notion that this disorder arises from the entrapment of circulating immune complexes in the kidney. Of importance is the fact that current assays have not been able to demonstrate the presence ofcomplexes in the sera ofa large number of such patients (4, 5) , suggesting that this may be a disease characterized by low levels of complexes. This is in contrast to other types ofglomerular disorders with either mesangial proliferation of fibrin deposition (6, 7) . (Alternatively, the lesions of membranous nephropathy may result from other immunopathogenetic mechanisms, such as in situ immune complex formation [8] [9] [10] [11] , as has been demonstrated for some models of nephritis.) Studies that have identified the presence of such complexes in the sera of a subpopulation of patients with this form of the disease, namely those with a concurrent renal vein thrombosis (12) , and in the sera of occasional patients with this disorder (13) , attest to the potential role of circulating immune complexes in the genesis of the renal lesion.
We propose a hypothesis that accounts for the distinctive abnormalities of this disease-that whatever the inciting etiologic agent, there is a defect in the ability of the host to mount an effective antibody response, leading to complexes being formed in large antigen excess, resulting in small-sized complexes that have been found in the serum of animals developing membranous nephropathy in the model of chronic serumsickness nephritis (2) . Further, because the available amount of antibody would be small, the concentrations of complexes generated would be correspondingly re-(lIicedl. The postulate that patients with membranous nephropathy have a (lefective antibody response also provides a rationale for the alternative mechanism of renail injury, namilely, int sitlu immune complex formation; the reduced antibody concentrations would facilitate anitigen implanitation in the glomerulus, allowing local formatioin of antigen-antibody complexes. To test the validity of this hypothesis, we have examiinied the ability of peripheral blood lymphocytes of these patients to produce immunoglobulin in response to a polyclonal B-cell activator, pokeweed mitogen (PWM).' We report here the finding that lymphocytes from patienits with imemiibranous nephropathy have a (diiii iislhedl capacity to produce immunoglobulin when culture(d in the presence of PWM. This defect is apparenitly the result of the presenice of a population Abbreviation nise(l in this paper: PWM, pokeweed mitogen. of suppressor cells that can inhibit the production of immunuioglobulin by the normal cells andl wlhose activity can be demonstrated by co-culture with normal lymphocytes. This suppressor cell has been identified as a monocyte.
METHODS
Patietnt selectioni. 11 patients, ages 17-62 yr, with a rencal histological dliagnosis of membranous glomerulonephropathv as defined by standard criteria, were studie(l (14) . The biopsies showed diffuse membranous thickening with spikes after staininig with the silver methanamiinie reagent, granular deposits of imimunoglobtilin, complemenit (C3) in onlv glomerular capillary loops by immnunofluorescence, anid subepithelial electron-dense deposits on electronmicroscopv. Durinig the perio(d of study, nonie of the patients had clinical or serologic evidcence of syphilis, hepatitis, systemic lupus erythematosus, or canicer. None of the patients had received any immnunosuppressive clrugs (inclu(ling steroids); the onlv imedicationi being taken was furosemide. Their clinical andl A.ssai1 sijsteni for iniiitinnnoglobulitn (Ig)G antd IgM produced biy Ijoinphoclte.s in culture. This is the method described by XValdmani et al. (15) . Lymphocytes were isolated from fresh heparinized blood (20 U preservative-free heparin/ml of blood) by Ficoll-Hypaque density gradients (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) by the method of Boyum (16) . Preparations were 90-95% viable as assessed by trypan blue dye exclusion. The lymphocytes were washedl exhaustively with balanced salt solution containinlg 5% heat-inactivated fetal calf serumil. The last wash was saved and found to be free of measurable imlniunoglobulin. The cells, at a concentration of 2 x 106 lyimlplhocytes/ml in RPMI-1640 medium (Grand Islandl Biological Co., Grand Island, N. Y.) supplemented with 2 mM glutaminie, 10% decomplemented fetal calf serum, 100 U/ml penicillini, and 100 ,g/ml streptomycin, were incubated in the presenice of 0, 5, 10, and 20 ,ul PWM at 37'C in a 5% C02-humllidifie(d atmosphere in 13 x 100-mm plastic culture tubes (Falconi Labware, Div. of Becton, Dickinson & Co., Oxnarcl, Calif). A maximum response was obtained with 10 ul of PWM andl results are expressed using this concentration of PWM. At the end of 7 d, culture tubes were centrifuged at 2,500 rpmii for 10 min. The amount ofIgG or IgM secreted into the culture mne(lia was determined by a double-antibody radioimmunoassav previously described (17) . The antisera used dicl not show cross-reactivity as assessed by immunoelectrophoresis and( immunoprecipitation with labeled antigen, precipitationl occurring only with the respective antigen-specific antiserum. 1-mg aliquots of IgG or IgM were labeled with 2-3 mCi 1251 using a chloramine-T procedure. The dilution of rabbit anti-IgG or anti-IgM that would bind 60% of an appropriate amount of labeled antigen was found. Antigen-antibody titration curves were constructed over an antigen range of 100-1,000 ng of immunoglobulin and 1:10-1:1,000 dilution of antisera. Twice the equivalent amount of goat anti-rabbit gammllea globulin was used to precipitate the rabbit immunoglobulin. In the actual procedure, 0.05 ml of culture supernate (or standard) and 10 ng of labeled antigen were adlded to an equal volume of anti-IgG or anti-IgM at room temperature for 3 h. Then 0.05 ml of goat anti-rabbit gammiiiia globulin was added with further incubation for 15 h at 4°C when 1.0 ml of 0.01 M Tris buffer pH 7.4 was pipetted to each tube. Tubes were centrifuged at 2,000 g for 20 min at 40C with recovery of the pellets for counting. The binding of labeled imtmunoglobulin could be inhibited up to 90% by cold-specific immunoglobulin. When 90-95% of the added amount was detected, recovery experimiients were also performecl using knowtv amounits of immunoglobulin.
Additionally, supernates of cell cultures from normal subjects and from patients with membranous nephropathy were assayed for immunoglobulin concentration by a solid phase fluorescence immunoassay (Immnuno-Fluor, Bio-Rad Laboratories, Richmond, Calif.) previously described in detail (18) . The reagents consist of derivatizedl polyacrylamide beads covalently coupled to rabbit anti-humani heavy-chain specific antibody and a soluble fluorescein-conjugated mnonospecific anti-human heavy-chain antiserum. 10-,u aliquots of culture supernate (or standard supplied by the manufacturer) were added to 12 x 75-mm borosilicate glass tubes, followed by 1.0 ml of the reconstituted solid-state immunoabsorbent (Immunobead, Bio-Rad Laboratories) with mixinig. The tubes were incubated at 37°C for 1.5 h. A 50-,ul aliquot of the appropriate antisera was then added to each tube with further mixing. The sample was incubated at 370C for another hour. The tubes were centrifuged at 1,700 g for 8 min; the supernate was decanted and the precipitate washed with 3 ml phosphatebuffered saline. The tubes were again centrifuged, supernates removed, and the precipitate resuspended in 3.0 ml phosphate-buffered saline; fluorescence in each sample was determined in a spectrofluorometer (Aminco-Bowmnani American Instrument Co., Silver Spring, Md.) using filters at excitation wavelength of 485 nmn and emission wavelength of 525 nm. Corrected relative fluorescence equals the value of the sample minus the reading of the reagent blank. The amount of bound fluorescent antibody is directly proportional to the amount of antigen absorbed by the solid-state reagent. The immunoglobulin concentration of the sample wvas cletermined from the standard curve. Values obtained by this assay and the radioimmunoassay gave highlv significant correlations: IgM, r = 0.98, P < 0.01; IgG, r = 0.97, P < 0.01.
For co-culture experiments, the techniques described by Broder et al. (19) were used. Using identical conditions as described above, an equal number (1 x 106) of lymphocytes from both normals and patients with membranous nephropathy were co-cultuired in the presence of 10 ,ul of PWNM. The results were expressed as percent of expected immnunoglobulin (Ig) produced by cells in co-culture: Amount of Ig produced by cells in co-culture x 100.
1/2 x (sum of Ig produced by cells of each individual culture separately)
Percent suppression of immunoglobulin produce( = 100percent of expected immunoglobulin produced by cells in co-culture. 10 experiments were done using lymphocytes as controls from paired normal subjects. Co-cultures were also done using lymphocytes from uremic and nephrotic control patients mixed with normal lymphocytes. Cultures were also performed using 2 x 106 lymphocytes from each subject (4 x 106 cells in 2 ml of mediumn) with similar results. All experiments were done in duplicate, incorporating control and patient samples in each run.
Evaluatiotn of the suppressor cell. To determine whether the suppressor cell was a mononuclear phagocyte cell or a T cell, or both, cultures and co-cultures were done concurrently, using lymphocytes depleted selectively of each cell type. To remove phagocytes, lymphocytes were prepared bv prior incubation of 50 ml of blood with 250 mig sterile carbonyl ironi powder (Gallard-Schlesinger Chemical Mfg.
Corp., Carle Place, N. Y.) at 37°C for 30 min in 5% CO2 with continuous agitation. Iron-ingested cells were removed by differential centrifugation using Ficoll-Hypaque gradients. The resultant lymphocyte preparations contained <1% monocytes, as assessed by latex particle ingestioni and morphology (20) .
Lymphocytes were depleted of T cells by removing sheep erythrocyte receptor-bearing lymphocytes in Ficoll-Hvpaque density gradienits (17) . Plastic tubes containing 0.5 ml of 5 x 106 lymphocytes/mI suspension were incubated with an equal volume of 0.5% sheep erythrocytes for 5 min at 37°C.
Mixtures were centrifuiged at 200 g for 5 min, followed by incubation for 4 h at 4°C. The erythrocyte-lymphocyte pellets were dispersed, pooled, and layered onto a Ficoll-Hypaque mixture (three parts 9% Ficoll and two parts 35% Hypaque). Centrifugation was done at 400 g for 40 min, and cells removed from the interface. The procedure was repeated with these cells and a B-cell-enriched fraction was obtained containing about 1-3% erythrocyte rosette-forming cells as determined by re-rosetting with sheep erythrocytes. Later experiments were done usinig the procedure described by Saxon et al. (21) , pretreating sheep erythrocytes with 2aminoethyl-isothiouronium bromide hvdrobromide.
()ta(ntitatiotn of peripheral blood mononut clear subpoputlations. T cells were identified by their ability to form rosettes with sheep erythrocytes (22) , B cells by their ability to form rosettes with sheep erythrocytes sensitized with IgM antibody and mouse (C3) number 3 (23) . Monocytes were identified by morphology and by latex particle ingestion. These determinations were done in seven patients.
Mfeasuremnenit of seruml iimmiunoglobtulitns. This was done by radial immuniodiffusioni (24) 
RESULTS
Serumiii i)lul ntoglobulini levels. The geomiietric imeans for serumLl immilunioglobulin levels in patienits with imembranous nephropathy were 436 mg/100 ml for IgG ancd 72 mg/100 ml for IgNM. The levels were significantly lower when compared with the geometric means of normual subjects: 919 mg/100 ml for IgG (t = 6.8, P < 0.01), 114 mg/100 ml for 1gM (t = 3.0, P < 0.01; Table I ). For nephrotic control patients (Table I) the geometric means were 406 mg/100 ml for IgG and 136 mg/100 ml for IgM, the former value being significantly lower than the normal geometric mean (t = 4.4, P < 0.01).
Enutmerationi of peripheral blood miontonuclear cell
subpopulations. The values (mean-+-SE) for seven patients were 75.6+1.6% for T cells, 17 .4+2.6% for B cells, and 10.3 ±0.7% for monocytes. These were within the normal ranges observed: T cells 63-78%, B cells 5-21%, monocytes 6-17%. In vitro sylnthesis of IgG and IgM by peripheral blood lymphocytes Fig. 1 . The geometric means of immunoglobulin production of normal subjects were 1,779 ng for IgG and 2,940 ng for IgM (per 2 x 106 cells after 7 d culture in the presence of 10 ul PWM). The peripheral blood lymphocytes of patients with membranous nephropathy produced significantly lower amounts of both immllunoglobulins, having geometric meanis of 511 ng for IgG (t =9.7, P < 0.01) and 439 ng for IgMl (t = 10.3, P < 0.01). This defect in immunioglobulin production was persistent in the four subjects tested on two conisecutive occasions at monthly intervals.
Lymphocytes from uremic patients and nephrotic control patients produced geometric mean concentrations of 1,636 and 1,442 ng IgG, respectively; the corresponding values for IgM for each group were 2,536 and 2,308 ng. These were not significantly different compared with normal values. The individual values of the patients are given in Tables I and II. Co-cuilti re experiments. To determine whether circulating suppressor cells were responsible for this defect in immiiuinoglobulin production, co-culture experimenits were done. The results are shown in Table  III . In experiments done with mixtures of lymphocytes from the patients with membranious nephropathy and normal subjects, percent suppression ranging from 41 to 81% was observed for lymphocytes from 10 patients with regard to IgG production; lymphocytes from all 11 patients dlemonstrated significant suppressing capacity for IgN1, ranginig from 22 to 82%. In 10 co-culture experiments with lymphocytes from normiial subjects, the percent suppression did not exceed 10% for IgG and 7% for IgM. The results of co-cultuire experiments between normal lymphocytes ancd cells from nephrotic control patients are shown in Table IV . Suppressive activity did not exceed 8% for IgG and 7% for IgM. Lymphocytes from five uremic subjects tested did not exhibit significant suppressive activity: 9% for IgG and 8% for IgM. Experiments using fractionated lymphocytes to determine the identity of the suppressor cell. The results are shown in Table V . When normal lymphocytes were co-cultured with patient lymphocytes subtracted of T cells, suppression was maintained at the same level as with unfractionated lymphocytes. However, when monocytes were removed, the suppressive activity was completely abolished. Additionally, in two experiments, when patient lymphocytes (2 x 106 cells) were depleted of monocytes and cultured alone, the production of immunoglobulin rose, in one case, from 410 to 1,412 ng IgG and, in the other case, from 387 to 1,760 ng IgG. In comparison, the results of culture and co-culture experiments using lymphocytes from nephrotic control patients are shown in Table VI . No significant increase in immunoglobulin production resulted from the removal ofmonocytes in these experiments.
DISCUSSION
The present study clearly delineates a defect in the ability of peripheral blood lymphocytes from patients with membranous nephropathy to produce normal amounts of IgG and IgM on stimulation with PWM. The defect was not related to either the renal functional status of the patient or the nephrotic state per se because control experiments done with lymphocytes from patients who were either uremic or nephrotic did not reveal similar findings. Additionally, investigations by others have shown normal immunoglobulin synthesis by lymphocytes from patients with lipoid nephrosis (25) . The inability of peripheral blood lymphocytes from patients with membranous nephropathy to produce adequate amounts of immunoglobulin was shown to be the result of a population of suppressor cells whose activity could be demonstrated, when normal immunoglobulin production was suppressed, by co-culturing with normal lymphocytes. By mixing experiments using lymphocytes depleted selectively of either T cells or monocytes, identification of the monocyte as the suppressor cell was established. Suppressor activity was nullified only with removal of monocytes. From studies of patients with multiple myeloma and sarcoidosis (17, 26) , there is precedent for the monocyte as a suppressor cell. The monocyte has been found to elaborate a variety of immunoregulatory substances, some of which inhibit lymphocyte function (27) .
The significance of these observations relates to the partial validation of the hypothesis proposed. The restrictions on the interpretation of the data are acknowledged. The function of only one pool of lymphocytes is being tested. Although PWM has been used previously to explore the cellular aberrations of patients with a variety of immune disorders (15, 17, 19, 26, (28) (29) (30) (31) (32) , there is only limited information to indicate that a defective B-cell response to this substance is paralleled by a diminished response of these cells to antigenic challenge (17) . It is also apparent that the demonstration of a poor antibody response to antigen- For 7 d, in the presence of 10,l PWM, lymphocytes (1 x 106 cells) from normal persons were cultured with an equal number of cells from patients with various forms ofrenal disease. Percent inhibition was calculated as described in Methods. Negative percentages denote that the amount of immunoglobulin produced exceeded the amount expected. specific challenge would be the critical observation. However, the nature of the antigen(s) in this form of progressive glomerulon-ephritis is unknown, and the relative unresponsiveness of lymphocytes to a polyclonal B-cell stimulation with PWM provides reasonable evidence ofa B-cell defect in these patients. These findings are consistent with the pathogenetic mechanisms responsible for the production of membranous nephropathy in one of the animal models studied, namely, chronic serum-sickness nephritis. In chronic serum-sickness nephritis, the classic studies of Dixon et al. (33) clearly demonstrate that only rabbits exhibiting a poor antibody response to the inciting antigen would develop progressive renal disease. These observations were extended by Germuth and Rodriguez (2) who related the morphologic expression of nephritis to the size of the circulating immune complex and showed that membranous nephropathy occurred in animals developing a very poor anti-body response, allowing the production of small-sized immune complexes formed presumably in large antigen excess. The results of another study provide additional support for Germuth's hypothesis. In an investigation using the active serum-sickniess nephritis model, the serum of the single animal developing membranous nephropathy was shown to contain an immune complex of relatively small size (34) . Parenthetically, it must be stated that the size of the antibody response exerts a critical role only when constant doses of antigen are given to the animal (35) . The ratio of antigen to antibody is the more critical determinant (35) . Other properties of either the antigen (such as its valence) or the antibody (affinity for the antigen) have also been shown to be important in determining the localization ofcomplexes in the glomerulus, probably by influencing their size (36 * Peripheral blood mononuclear (PBL) cells (2 x 106 cells) were cultured either by themselves or after monocyte depletion. Unfractionated or fractionated patient cells (1 x 106 cells) were co-cultured with an equal number ofnormal cells; all cultures were done with 10 Il PWM for 7 d. Percent inhibition was calculated as in Methods. Negative percentages denote that the amount ofimmunoglobulin produced exceeded that expected.
anti-DNA antibodies in their sera (37, 38) . The study also showed that patients with lupus membranous nephropathy had significantly lower titers of serum anti-DNA antibody compared with patients with other forms of lupus nephritis, an observation that supports the current findings. Mention must be made of the alternative model of membranous nephropathy, namely, Heyman's nephritis. Recent experiments have demonstrated that renal injury in this model results from the interaction of antibody with an antigen that is an integral component of glomerular structure (10, 11) . The relevance of our observations to this pathogenetic mechanism of membranous nephropathy is uncertain; at best they may provide an explanation for the indolent course of the illness.
Finally, it is acknowledged that the results of the present study do not exclude the presence of other potential mechanisms that may interfere with the immune responses, such as the presence of serum factors having immunoregulatory functions.
